Header cover image
  • Investing Ideas
  • Taiwanese Pharmaceuticals & Biotech Large Cap High Growth Potential

Taiwanese Pharmaceuticals & Biotech Large Cap High Growth Potential

Results

1

0 new

Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.

1 companies

PharmaEssentia

Market Cap: NT$529.7b

A biopharmaceutical company engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug patterns developments in the Americas, Europe, Asia, and Taiwan.

6446

NT$1,285.00

7D

-1.4%

1Y

201.9%